Caixin
Aug 26, 2022 08:00 AM

Guanhao Biotech Co.,Ltd. Posted 247.2 Million Yuan Net Loss in First Half of 2022

Guanhao Biotech Co.,Ltd. (冠昊生物科技股份有限公司) (300238.SZ) reported a net loss of 247.2 million yuan in the first half of 2022, reversing a net profit of 33 million yuan for the same period in the previous year.

Meanwhile, the company posted 202.9 million yuan in revenue, down 22.7% year-on-year.

At the end of the reporting period, it had 794.7 million yuan in total assets and 289.8 million yuan in total liabilities, with a liability-to-asset ratio of 36.5%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST